FILTER
FILTERED INTERVIEW RESULTS
Louis Watum
PRESIDENT, CHAMBER OF MINES DRC
"I am concerned that the DRC is not fully capturing the opportunities of the commodity boom."
Hadley Natus
CHAIRMAN, TANTALEX LITHIUM RESOURCES
"I think Manono, for lithium, could become what Katanga has become for copper, and much more."
Eric Waldner
CEO, NEXANS KABELMETAL GHANA
"Ghana set an ambitious goal to be 100% electrified by 2024, which will be massively pushing our growth forward."
George Arhin
PARTNER AND PWC WEST AFRICA MINING LEADER
"This is the best time for mining companies to invest in cost optimization solutions to sustain their business when the gold prices dip."
Stéphane Rabut
GLOBAL EXPLOSIVES DIRECTOR, TITANOBEL
"Africa remains our primary focus, providing many opportunities driven by a vibrant mining industry, as well as less competition and the possibility of attaining a larger market share."
Doris Afanyedey
GENERAL MANAGER, CUMMINS GHANA
"The mining sector across West Africa is ripe with opportunities and we are looking to expand our network of dealers."
Tom Palmer
PRESIDENT AND CEO, NEWMONT
Tom Palmer discussed Newmont’s global operations, investments and ESG strategy.
Catherine Warburton
MANAGING DIRECTOR, WARBURTON ATTORNEYS INC
"The firm specializes in the dynamic field of sustainability law, focusing on environmental law, energy law, mining law and policy, and occupational and mine health and safety law."
Asimwe Kabunga
CHAIRMAN, LINDIAN RESOURCES LIMITED
"With near-term export options, exceptional quality material and a multi-generational resource base, Lindian is well placed to become the best bauxite development company in the world."
Nana Sangmuah
CEO, ROSCAN GOLD
"Sandwiched between two of the largest producing assets in West Africa and with our six discoveries made already, we hope to join the league of tier-one mines."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
